CHO | Control | CHO + W3 | W3 | P value | |
---|---|---|---|---|---|
(n = 14) | (n = 14) | (n = 15) | (n = 14) | ||
LVEF | 0.55 ± 0.12 (0.60) | 0.57 ± 0.11 (0.60) | 0.54 ± 0.13 (0.60) | 0.62 ± 0.11 (0.65) | 0.168a |
Smoking | 6 (43) | 9 (64) | 7 (47) | 8 (57) | 0.653b |
Diabetes | 4 (29) | 3 (21) | 5 (33) | 6 (43) | 0.666b |
Dyslipidemia | 11 (79) | 12 (86) | 8 (53) | 11 (79) | 0.204b |
Previous AMI | 7 (50) | 9 (64) | 6 (40) | 7 (50) | 0.631b |
Beta-blocker use | 9 (64) | 10 (71) | 6 (40) | 11 (79) | 0.151b |
Statin use | 11 (79) | 11 (79) | 9 (60) | 11 (79) | 0.580b |
Fibrate use | 2 (14) | 2 (14) | 2 (13) | 3 (21) | 0.930b |
Previous PCI | 1 (7) | 4 (29) | 4 (27) | 3 (21) | 0.495b |